These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 39364290

  • 1. High-grade serous ovarian cancer development and anti-PD-1 resistance is driven by IRE1α activity in neutrophils.
    Emmanuelli A, Salvagno C, Hwang SM, Awasthi D, Sandoval TA, Chae CS, Cheong JG, Tan C, Iwawaki T, Cubillos-Ruiz JR.
    Oncoimmunology; 2024; 13(1):2411070. PubMed ID: 39364290
    [Abstract] [Full Text] [Related]

  • 2. High-grade serous ovarian cancer development and anti-PD-1 resistance is driven by IRE1α activity in neutrophils.
    Emmanuelli A, Salvagno C, Min-Hwang S, Awasthi D, Sandoval TA, Chae CS, Cheong JG, Tan C, Iwawaki T, Cubillos-Ruiz JR.
    bioRxiv; 2024 Aug 07. PubMed ID: 39211073
    [Abstract] [Full Text] [Related]

  • 3. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
    Li R, Liu T, Shi J, Luan W, Wei X, Yu J, Mao H, Liu P.
    J Transl Med; 2019 Dec 26; 17(1):428. PubMed ID: 31878941
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity.
    Song M, Sandoval TA, Chae CS, Chopra S, Tan C, Rutkowski MR, Raundhal M, Chaurio RA, Payne KK, Konrad C, Bettigole SE, Shin HR, Crowley MJP, Cerliani JP, Kossenkov AV, Motorykin I, Zhang S, Manfredi G, Zamarin D, Holcomb K, Rodriguez PC, Rabinovich GA, Conejo-Garcia JR, Glimcher LH, Cubillos-Ruiz JR.
    Nature; 2018 Oct 26; 562(7727):423-428. PubMed ID: 30305738
    [Abstract] [Full Text] [Related]

  • 6. Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer.
    Wan C, Keany MP, Dong H, Al-Alem LF, Pandya UM, Lazo S, Boehnke K, Lynch KN, Xu R, Zarrella DT, Gu S, Cejas P, Lim K, Long HW, Elias KM, Horowitz NS, Feltmate CM, Muto MG, Worley MJ, Berkowitz RS, Matulonis UA, Nucci MR, Crum CP, Rueda BR, Brown M, Liu XS, Hill SJ.
    Cancer Res; 2021 Jan 01; 81(1):158-173. PubMed ID: 33158814
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Endoplasmic reticulum stress sensor IRE1α propels neutrophil hyperactivity in lupus.
    Sule G, Abuaita BH, Steffes PA, Fernandes AT, Estes SK, Dobry C, Pandian D, Gudjonsson JE, Kahlenberg JM, O'Riordan MX, Knight JS.
    J Clin Invest; 2021 Apr 01; 131(7):. PubMed ID: 33561013
    [Abstract] [Full Text] [Related]

  • 9. Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer.
    Strickland KC, Howitt BE, Shukla SA, Rodig S, Ritterhouse LL, Liu JF, Garber JE, Chowdhury D, Wu CJ, D'Andrea AD, Matulonis UA, Konstantinopoulos PA.
    Oncotarget; 2016 Mar 22; 7(12):13587-98. PubMed ID: 26871470
    [Abstract] [Full Text] [Related]

  • 10. Immune escape between endoplasmic reticulum stress-related cancer cells and exhausted CD8+T cells leads to neoadjuvant chemotherapy resistance in ovarian cancer.
    Zhang S, Zhang Y, Song X, Wang X, Quan L, Xu P, Zhao L, Song W, Liu Q, Zhou X.
    Biochem Biophys Res Commun; 2024 Nov 12; 733():150686. PubMed ID: 39278093
    [Abstract] [Full Text] [Related]

  • 11. CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.
    Yang M, Lu J, Zhang G, Wang Y, He M, Xu Q, Xu C, Liu H.
    J Immunother Cancer; 2021 Jan 12; 9(1):. PubMed ID: 33452206
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tumor-associated macrophage expression of PD-L1 in implants of high grade serous ovarian carcinoma: A comparison of matched primary and metastatic tumors.
    Gottlieb CE, Mills AM, Cross JV, Ring KL.
    Gynecol Oncol; 2017 Mar 12; 144(3):607-612. PubMed ID: 28065619
    [Abstract] [Full Text] [Related]

  • 14. IRE1α dissociates with BiP and inhibits ER stress-mediated apoptosis in cartilage development.
    Han X, Zhou J, Zhang P, Song F, Jiang R, Li M, Xia F, Guo FJ.
    Cell Signal; 2013 Nov 12; 25(11):2136-46. PubMed ID: 23816533
    [Abstract] [Full Text] [Related]

  • 15. IRE1α Disruption in Triple-Negative Breast Cancer Cooperates with Antiangiogenic Therapy by Reversing ER Stress Adaptation and Remodeling the Tumor Microenvironment.
    Harnoss JM, Le Thomas A, Reichelt M, Guttman O, Wu TD, Marsters SA, Shemorry A, Lawrence DA, Kan D, Segal E, Merchant M, Totpal K, Crocker LM, Mesh K, Dohse M, Solon M, Modrusan Z, Rudolph J, Koeppen H, Walter P, Ashkenazi A.
    Cancer Res; 2020 Jun 01; 80(11):2368-2379. PubMed ID: 32265225
    [Abstract] [Full Text] [Related]

  • 16. Deubiquitinase UCHL1 Maintains Protein Homeostasis through the PSMA7-APEH-Proteasome Axis in High-grade Serous Ovarian Carcinoma.
    Tangri A, Lighty K, Loganathan J, Mesmar F, Podicheti R, Zhang C, Iwanicki M, Drapkin R, Nakshatri H, Mitra S.
    Mol Cancer Res; 2021 Jul 01; 19(7):1168-1181. PubMed ID: 33753553
    [Abstract] [Full Text] [Related]

  • 17. Oncolytic adenovirus MEM-288 encoding membrane-stable CD40L and IFNβ induces an anti-tumor immune response in high grade serous ovarian cancer.
    Peters PN, Whitaker RS, Lim F, Russell S, Bloom EA, Pollara J, Strickland KC, Cantwell MJ, Beg A, Berchuck A, Antonia S, Previs RA.
    Neoplasia; 2024 Nov 01; 57():101056. PubMed ID: 39276533
    [Abstract] [Full Text] [Related]

  • 18. A spatial proteomic study of platinum refractory HGSOC implicates dual AKT and WNT activity linked to an immunosuppressive tumor microenvironment.
    Scalise CB, Kincaid K, Thigpen H, Moore J, Dover B, Norian L, Meza-Perez S, Randall T, Birrer M, Odunsi K, Arend RC.
    Gynecol Oncol; 2024 Jun 01; 185():83-94. PubMed ID: 38377762
    [Abstract] [Full Text] [Related]

  • 19. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q, Shi G, Chen X, Lin Y, Cheng L, Jiang Q, Yan X, Jiang M, Li Y, Zhang H, Wang H, Wang Y, Wang Q, Zhang Y, Liu Y, Su X, Dai L, Tang M, Li J, Zhang L, Qian Z, Yu D, Deng H.
    Theranostics; 2020 Jun 01; 10(18):8382-8399. PubMed ID: 32724476
    [Abstract] [Full Text] [Related]

  • 20. ER stress and distinct outputs of the IRE1α RNase control proliferation and senescence in response to oncogenic Ras.
    Blazanin N, Son J, Craig-Lucas AB, John CL, Breech KJ, Podolsky MA, Glick AB.
    Proc Natl Acad Sci U S A; 2017 Sep 12; 114(37):9900-9905. PubMed ID: 28847931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.